10.3 Pediatric Leukemias, Solid Tumors & Oncologic Emergencies

Pediatric Leukemias, Solid Tumors & Oncologic Emergencies

Quick Overview: Pediatric oncology requires rapid diagnostic acumen, strict procedural safety, and aggressive management of life-threatening oncologic emergencies. Acute lymphoblastic leukemia (ALL) represents the predominant pediatric malignancy, characterized by blast-cell bone marrow infiltration and bone marrow failure pancytopenia. Solid tumors exhibit stark developmental contrasts, exemplified by encapsulated Wilms renal tumors—where abdominal palpation is strictly forbidden to prevent peritoneal seeding—versus aggressive neuroblastomas that cross the midline and produce periorbital metastases. When cytoreductive chemotherapy begins, massive cellular breakdown precipitates Tumor Lysis Syndrome (TLS), demanding vigorous IV hyperhydration and rasburicase, while chemotherapy-induced myelosuppression leaves patients defenseless against fulminant Febrile Neutropenia, mandating empiric antipseudomonal monotherapy within the sixty-minute 'Golden Hour'.

---

1. Acute Lymphoblastic Leukemia (ALL): Biology, Presentation & Diagnosis

Acute lymphoblastic leukemia (ALL) accounts for approximately 75% to 80% of all childhood leukemias and represents roughly 25% of all childhood cancer diagnoses. The peak incidence occurs between 2 and 5 years of age, with a slight male predominance.

Cellular Pathophysiology & Risk Factors

• Malignant Transformation: ALL involves the uncontrolled, clonal proliferation of immature lymphoid progenitor cells (lymphoblasts) arrested at an early stage of differentiation.
• Lineage Classification: Approximately 85% are precursor B-cell ALL, while 15% are T-cell ALL (which more frequently presents in adolescent males with high leukocyte counts and an anterior mediastinal mass).
• Predisposing Genetic Conditions: Children with Trisomy 21 (Down syndrome) face a 10- to 20-fold increased risk of developing acute leukemia. Other predisposing syndromes include Fanconi anemia, Bloom syndrome, Ataxia-telangiectasia, and Neurofibromatosis type 1.

Clinical Manifestations of Bone Marrow Infiltration: The Pancytopenia Triad

As malignant lymphoblasts proliferate within the confined medullary cavity of the bone marrow, they crowd out and physically replace normal hematopoietic stem cells (erythroid, myeloid, and megakaryocytic lineages), precipitating the classic clinical triad of bone marrow failure:

1. Erythrocyte Suppression (Anemia): Profound pallor, chronic fatigue, malaise, exertional dyspnea, resting tachycardia, headache, and poor feeding.
2. Granulocyte Suppression (Neutropenia): Persistent, unexplained fevers, recurrent bacterial or fungal infections, oral mucositis, and delayed wound healing. Despite an elevated total white blood cell count on automated counters, the circulating cells are non-functional immature blasts; the child is functionally severely neutropenic.
3. Megakaryocyte Suppression (Thrombocytopenia): Spontaneous cutaneous petechiae, widespread ecchymoses, recurrent epistaxis, bleeding gums with toothbrushing, and prolonged oozing from puncture sites.

Extramedullary Infiltration Findings

• Bone and Joint Pain: Present in up to 40% to 50% of children, caused by blast accumulation beneath the periosteum and pressure within the medullary expansion. Manifests as an antalgic limp, refusal to bear weight, or complaints of severe leg and back pain, frequently misdiagnosed as "growing pains" or juvenile idiopathic arthritis.
• Reticuloendothelial Infiltration: Painless, non-tender, generalized lymphadenopathy (cervical, axillary, inguinal), hepatomegaly, and splenomegaly (present in > 60% of cases).
• Central Nervous System (CNS) Infiltration: Blasts cross the blood-brain barrier to colonize the leptomeninges. Signs of elevated intracranial pressure include severe morning headache, vomiting without nausea, papilledema, and cranial nerve palsies (particularly cranial nerves VI and VII).
• Testicular Enlargement: Painless, firm, unilateral or bilateral testicular swelling. The testicles and CNS represent sanctuary sites where standard systemic chemotherapeutic agents penetrate poorly due to physiological blood-tissue barriers.
• Mediastinal Mass (T-Cell ALL): Compression of the trachea and superior vena cava (SVC syndrome), presenting with cough, stridor, wheezing, dyspnea, orthopnea, and facial/neck edema.

Diagnostic Evaluation & Risk Stratification

• Peripheral Blood Smear: Often reveals anemia, thrombocytopenia, and circulating lymphoblasts. The total WBC count can be low (< 4,500/mcL), normal, or markedly elevated (> 50,000 to 100,000/mcL).
• Bone Marrow Aspiration & Biopsy (DEFINITIVE GOLD STANDARD): Typically obtained from the posterior superior iliac spine under procedural sedation. Diagnostic criteria require >= 20% to 25% lymphoblasts of total marrow cellularity (often exceeding 80% to 90%).
• Immunophenotyping & Flow Cytometry: Differentiates B-lineage (CD10, CD19, CD22) from T-lineage (CD3, CD5, CD7) blasts.
• Cytogenetics & Molecular Testing:
  • Favorable Prognosis: Hyperdiploidy (> 50 chromosomes) and ETV6-RUNX1 fusion gene [t(12;21)].
  • Unfavorable Prognosis: Hypodiploidy (< 44 chromosomes), KMT2A (MLL) gene rearrangements [t(4;11)], and the Philadelphia chromosome [t(9;22) BCR-ABL1] (which requires targeted tyrosine kinase inhibitor therapy like imatinib).
• Lumbar Puncture (LP): Mandatory at diagnosis to evaluate cerebrospinal fluid (CSF) cytocentrifugation for leukemic blasts, establishing CNS staging (CNS-1, CNS-2, CNS-3).

---

2. Chemotherapeutic Protocols & CNS Prophylaxis in ALL

Modern risk-directed chemotherapy protocols achieve complete cure rates exceeding 90% in pediatric ALL through sequential therapeutic phases:

1. Induction Phase (4 to 6 weeks):
   • Goal: Eradicate > 99% of initial tumor burden and induce complete clinical remission, defined as < 5% leukemic blasts in the bone marrow with recovery of normal peripheral blood counts.
   • Standard Three- or Four-Drug Regimen: Vincristine, a corticosteroid (Dexamethasone or Prednisone), and PEG-asparaginase, plus an anthracycline (Daunorubicin) for high-risk patients.
   • Critical Nursing Monitoring: Vincristine causes peripheral neuropathy (foot drop, loss of deep tendon reflexes, severe constipation/paralytic ileus); PEG-asparaginase causes anaphylaxis, acute pancreatitis, and coagulopathy; corticosteroids cause hyperglycemia, hypertension, mood lability, and ravenous appetite.
2. Consolidation / Intensification Phase:
   • Goal: Destroy submicroscopic residual leukemic clones to prevent relapse, monitored via Minimal Residual Disease (MRD) flow cytometry.
3. Central Nervous System (CNS) Prophylaxis:
   • Because systemic chemotherapeutic agents penetrate poorly across the blood-brain barrier, untreated patients experience CNS relapse in over 50% of cases.
   • Intrathecal (IT) Chemotherapy: Mandatory for all patients. Administered via regular lumbar punctures throughout all phases of treatment using Intrathecal Methotrexate, triple intrathecal therapy (methotrexate, cytarabine, hydrocortisone), or cranial irradiation (reserved exclusively for overt CNS leukemia).
4. Maintenance / Continuation Phase (2 to 3 years):
   • Extended outpatient chemotherapy: Daily oral 6-Mercaptopurine (6-MP) and weekly oral Methotrexate, combined with periodic pulses of vincristine and dexamethasone.

---

3. Wilms Tumor (Nephroblastoma): Pathophysiology, Presentation & Palpation Ban

Wilms tumor (nephroblastoma) is the most common primary malignant renal tumor in children, representing 6% to 7% of all pediatric malignancies. The peak incidence occurs between 2 and 3 years of age, with > 90% diagnosed before age 5.

Pathophysiology & Associated Genetic Syndromes

• Embryonal Origin: Arises from persistent metanephric blastema—embryonic precursor tissue destined to form mature renal structures. Histologically, it demonstrates a triphasic pattern (blastemal, stromal, and epithelial elements).
• Anatomical Presentation: Typically presents as a large, solitary, encapsulated mass arising within the renal parenchyma. The tumor expands, stretching the renal capsule into a delicate pseudocapsule. Usually unilateral (95%); bilateral in 5% to 7%.
• Associated Genetic Syndromes:
  • WAGR Syndrome: WT1 gene deletion on chromosome 11p13; characterized by Wilms tumor, Aniridia (absence of the iris), Genitourinary malformations (cryptorchidism, hypospadias), and Range of developmental delay.
  • Beckwith-Wiedemann Syndrome: WT2 mutation on chromosome 11p15; characterized by hemihypertrophy (asymmetric body overgrowth), macroglossia (enlarged tongue), omphalocele, and hypoglycemia in infancy.
  • Denys-Drash Syndrome: Severe nephropathy, diffuse mesangial sclerosis, male pseudohermaphroditism, and extreme Wilms risk.

Clinical Presentation

• Classic Abdominal Mass: An asymptomatic, firm, non-tender, smooth mass or swelling discovered serendipitously by parents while bathing, diapering, or dressing the child, or during a routine well-child physical exam.
• Unilateral & Confined: The mass is characteristically confined to one side of the flank and RARELY CROSSES THE ANATOMICAL MIDLINE.
• Hypertension (25% to 30%): Caused by tumor compression of adjacent healthy renal parenchyma and renal vasculature, triggering excessive renin secretion via the renin-angiotensin-aldosterone axis.
• Microscopic or Gross Hematuria (20% to 30%): Occurs when the tumor erodes into the renal collecting system.
• Abdominal discomfort, anorexia, low-grade fever, and anemia secondary to intra-tumoral hemorrhage.

CRITICAL NURSING SAFETY DIRECTIVE: THE PALPATION BAN

Multimodal Management

• Diagnostic Imaging: Abdominal ultrasound followed by contrast-enhanced CT or MRI of the abdomen and pelvis. Chest CT is mandatory to rule out pulmonary metastasis, which represents the most frequent site of distant spread (80% of metastases).
• Surgical Resection (Radical Nephrectomy): Complete surgical excision of the involved kidney, tumor, ureter, and regional lymph node sampling via transabdominal incision (avoiding puncture or spillage).
• Chemotherapy & Radiotherapy: Adjuvant chemotherapy with Vincristine and Dactinomycin (Actinomycin D) +/- Doxorubicin for advanced stages.
• Post-Operative Nursing Priorities: Strict monitoring of blood pressure, continuous recording of intake and output, and monitoring of renal function (BUN/creatinine) to safeguard the solitary remaining kidney.

---

4. Neuroblastoma: Neural Crest Origin, Metastatic Patterns & Diagnostics

Neuroblastoma is the most common extracranial solid tumor of infancy and childhood and represents the most frequently diagnosed malignancy in infants under 1 year of age. The median age at diagnosis is 18 to 22 months, with 90% diagnosed before age 5.

Pathophysiology & Primary Tumor Sites

• Embryological Origin: Arises from primitive sympathogonia (neural crest cells) that migrate to form the sympathetic nervous system and adrenal medulla.
• Anatomical Locations:
  • Adrenal Medulla (40% to 50%): Most common primary site.
  • Retroperitoneal / Paraspinal Sympathetic Chain (25% to 30%): Abdominal retroperitoneum.
  • Posterior Mediastinum (15%): Thoracic cavity.
  • Cervical Sympathetic Chain & Pelvis (5%): Neck or presacral area.

Clinical Manifestations: Contrasting Neuroblastoma vs. Wilms Tumor

Characteristic Clinical Signs of Neuroblastoma

• Periorbital Ecchymosis ("Racoon Eyes") & Proptosis: Caused by metastatic tumor infiltration of the retrobulbar orbital bones and sphenoid bone, with secondary peri-orbital microvascular bleeding. Frequently misdiagnosed as non-accidental trauma (child abuse).
• Horner Syndrome (Triad: Ptosis, Miosis, Anhidrosis): Occurs when cervical or apical thoracic tumors compress the cervical sympathetic ganglion chain.
• Spinal Cord Compression ("Dumbbell Tumors"): Paraspinal tumors that extend medially through the intervertebral foramina into the epidural space, presenting with progressive motor weakness, gait ataxia, loss of bowel/bladder sphincter continence, or flaccid paralysis. This represents an acute neuro-oncologic emergency requiring high-dose dexamethasone and emergent radiation or surgical decompression.
• Opsoclonus-Myoclonus-Ataxia Syndrome ("Dancing Eyes, Dancing Feet"): A rare paraneoplastic autoimmune syndrome characterized by rapid, irregular, chaotic conjugate eye movements (opsoclonus), myoclonic jerking of limbs, and severe cerebellar ataxia.

Laboratory & Genetic Diagnostics

• Urinary Catecholamine Metabolites: Excessive sympathetic catecholamine production leads to elevated 24-hour urinary Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA) in > 90% of cases.
• MIBG Scintigraphy (I-123 MIBG Scan): Radiotracer selectively concentrated by norepinephrine transporters in sympathetic neuroblastoma tissue, providing gold-standard whole-body staging of primary and metastatic bone/marrow disease.
• MYCN Oncogene Amplification: High-level genomic amplification of the MYCN proto-oncogene (> 10 copies) is the single most powerful adverse biological prognosticator, indicating aggressive, chemoresistant disease regardless of age or stage.

---

5. Oncologic Emergency: Tumor Lysis Syndrome (TLS)

Tumor Lysis Syndrome (TLS) is an acute, life-threatening metabolic oncologic emergency triggered by the massive, rapid lysis of malignant neoplastic cells and the immediate release of intracellular ions, nucleic acids, and proteins into the systemic circulation. It occurs spontaneously or within 12 to 72 hours following the initiation of cytotoxic chemotherapy.

High-Risk Pediatric Malignancies

TLS is most frequent in tumors characterized by rapid cellular turnover, high proliferative rates, and extensive tumor burden:

• Burkitt Lymphoma / Advanced Non-Hodgkin Lymphoma
• T-cell Acute Lymphoblastic Leukemia
• ALL with marked hyperleukocytosis (WBC > 100,000/mcL)

The Pathophysiological Metabolic Tetrad

Tumor Lysis Syndrome Metabolic Cascade:
├── 1. HYPERKALEMIA (> 6.0 mEq/L): Lysis releases intracellular K+ -> Peaked T waves, wide QRS, ventricular dysrhythmias, cardiac arrest
├── 2. HYPERPHOSPHATEMIA (> 6.5 mg/dL): Lysis dumps intracellular organic phosphorus -> Exceeds renal threshold -> Calcium phosphate precipitation
├── 3. SECONDARY HYPOCALCEMIA (< 7.0 mg/dL): Calcium complexes with phosphate -> Tetany, Chvostek/Trousseau signs, long QT, seizures
└── 4. HYPERURICEMIA (> 8.0 mg/dL): Massive purine nucleic acid breakdown -> Precipitation of uric acid crystals in renal tubules -> Acute kidney injury

1. Hyperkalemia (Serum Potassium > 6.0 mEq/L):
   • Intracellular potassium concentration (~140 mEq/L) is 30 times higher than extracellular fluid. Massive cell lysis floods circulation.
   • Manifestations: Muscle weakness, paresthesias, peaked T waves, flattened P waves, PR interval prolongation, widening of the QRS complex, ventricular fibrillation, and asystole.
2. Hyperphosphatemia (Serum Phosphate > 6.5 mg/dL):
   • Malignant lymphoblasts contain up to four times more intracellular phosphorus than normal lymphocytes.
   • Massive release exceeds the renal tubular excretory threshold. High circulating phosphate binds serum calcium, forming insoluble calcium phosphate salts that precipitate in renal tubules, myocardium, and microvasculature.
3. Secondary Hypocalcemia (Corrected Calcium < 7.0 mg/dL or Ionized Ca < 1.0 mmol/L):
   • Results directly from calcium phosphate crystallization. Low calcium causes acute neuromuscular irritability, muscle cramping, digital and perioral paresthesias, positive Chvostek sign (facial twitching with facial nerve percussion), positive Trousseau sign (carpopedal spasm with BP cuff inflation), prolonged QT interval, ventricular arrhythmias, and seizures.
4. Hyperuricemia (Serum Uric Acid > 8.0 mg/dL):
   • Massive breakdown of intracellular purine nucleic acids (adenine and guanine) converts purines to hypoxanthine, then to xanthine, and finally to uric acid via the hepatic enzyme xanthine oxidase.
   • Uric acid exhibits low solubility in acidic urine (pH < 5.5). It crystallizes within the renal collecting tubules and microcapillaries, causing acute mechanical obstruction, tubulointerstitial nephritis, and oliguric/anuric acute kidney injury.

Prevention & Management Protocols

• Risk-based IV hydration: Use the oncology protocol and current renal/cardiac status. For example, CHOP's pathway uses maintenance, 1.5 times maintenance, or 2 times maintenance according to risk and clinical state, with frequent electrolyte, renal, weight, and fluid-balance assessment. Do not apply a blanket four-times-maintenance order. Avoid routine potassium addition while TLS risk is high and adjust composition to measured values and specialist direction. CHOP tumor lysis pathway.

• Hypouricemic Pharmacotherapy:

  • Allopurinol (Oral / IV): Competitive inhibitor of xanthine oxidase. Prevents the new enzymatic conversion of hypoxanthine and xanthine to uric acid. Indicated for low- to moderate-risk TLS. Limitation: Does not degrade existing uric acid and requires 2 to 3 days to achieve peak clinical effect.
  • Rasburicase (Recombinant Urate Oxidase):
    • Genetically engineered enzyme that directly catalyzes the enzymatic oxidation of established, circulating uric acid into allantoin.
    • Allantoin is an inactive, highly soluble metabolite (5 to 10 times more soluble than uric acid) that is cleared rapidly by the kidneys.
    • Clears serum uric acid within 4 hours of administration. Indicated for high-risk TLS or existing hyperuricemia.
    • ABSOLUTE SAFETY CONTRAINDICATION (G6PD DEFICIENCY): Rasburicase is STRICTLY CONTRAINDICATED in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency! The enzymatic conversion of uric acid to allantoin generates hydrogen peroxide as a chemical byproduct. In G6PD-deficient erythrocytes lacking NADPH and glutathione defense, hydrogen peroxide oxidizes hemoglobin into methemoglobin and denatures red cells, triggering catastrophic methemoglobinemia and life-threatening massive intravascular hemolytic anemia!
    • CRITICAL LABORATORY DRAWING DIRECTIVE: Blood samples drawn for serum uric acid determination in patients receiving rasburicase MUST BE COLLECTED IN PRE-CHILLED HEPARIN TUBES AND IMMEDIATELY PLACED ON WET ICE and hand-delivered to the lab. If left at room temperature, rasburicase continues enzymatic degradation of uric acid ex vivo in the test tube, yielding falsely depressed, spuriously normal uric acid results!

• Electrolyte emergencies: Obtain continuous cardiac monitoring, escalate urgently, and use the institution's pediatric hyperkalemia pathway. IV calcium stabilizes the myocardium when indicated but does not remove potassium. Insulin/glucose and other prescribed measures require precise concentration, dose, glucose monitoring, and reassessment. In TLS, calcium administration also requires attention to phosphate and precipitation risk. Refractory hyperkalemia or severe overload may require renal replacement therapy. Avoid treating a generic calcium dose or a slow potassium-binding resin as a complete emergency protocol.

---

6. Oncologic Emergency: Febrile Neutropenia

Febrile neutropenia is a medical emergency that represents the leading cause of treatment-related mortality in pediatric cancer patients undergoing myelosuppressive chemotherapy.

Clinical Definitions & Diagnostic Criteria

1. Neutropenia Definition:
   • Absolute Neutrophil Count (ANC) < 500/mcL, OR an ANC < 1,000/mcL with an anticipated decline to < 500/mcL within the subsequent 48 hours.
   • Severe Neutropenia: ANC < 200/mcL (highest risk for invasive bacteremia).
2. The Absolute Neutrophil Count (ANC) Calculation Formula:

ANC = Total WBC x [(% Segmented Neutrophils + % Band Neutrophils) / 100]

Worked Clinical Example for Exam: A 6-year-old undergoing chemotherapy has a CBC revealing: Total WBC = 1,200/mcL, Segmented neutrophils = 18%, Band neutrophils = 6%. What is the ANC?

• Sum of neutrophils: 18% + 6% = 24% (0.24)
• ANC calculation: 1,200 x 0.24 = 288/mcL
• Clinical Interpretation: The child is severely neutropenic (ANC < 500/mcL).

1. Fever Definition in Pediatric Oncology:
   • A single oral or core temperature >= 38.3°C (101.0°F), OR
   • A sustained temperature >= 38.0°C (100.4°F) for at least 1 hour.

Pathophysiological Crisis: The Absence of Signs

Neutrophils are the primary inflammatory effector cells responsible for producing erythema, warmth, purulence (pus), swelling, and localized pain. In a neutropenic child, local signs of infection are completely absent (e.g., pneumonia produces no pulmonary infiltrates or sputum; meningitis produces no CSF pleocytosis; cellulitis exhibits no induration or pus). FEVER IS FREQUENTLY THE SOLE CLINICAL MANIFESTATION OF OVERWHELMING BACTEREMIA! Gram-negative organisms (Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae) can progress from an initial spike of fever to septic shock, refractory hypotension, and death within hours.

Emergency Protocol: "The Golden Hour"

1. Immediate Diagnostic Cultures:
   • Draw blood cultures immediately from EACH lumen of all central venous lines (Port-a-Cath, Hickman, PICC line) PLUS a peripheral venipuncture blood culture. Each lumen must be cultured because bacterial biofilms can colonize a single lumen.
   • Obtain clean-catch midstream urine culture (if toilet trained) or catheterized culture; swab visible mucosal lesions.
2. Immediate Broad-Spectrum Antipseudomonal IV Monotherapy:
   • Administer an empiric broad-spectrum antipseudomonal beta-lactam agent immediately: Cefepime (50 mg/kg IV q8h), Piperacillin-Tazobactam (Zosyn 75 to 100 mg/kg IV q6h), or Meropenem (20 mg/kg IV q8h).
   • NEVER delay antibiotic infusion waiting for blood culture draws to complete if difficult access, waiting for CBC results, or waiting for chest radiography!
   • Add IV Vancomycin if hemodynamic instability (hypotension, tachycardia), suspected catheter tunnel infection, known colonization with Methicillin-Resistant Staphylococcus aureus (MRSA), or severe oral mucositis.

Protective Neutropenic Precautions

• Strict Hand Hygiene: The single most effective measure to prevent nosocomial pathogen transmission.
• Private Room: Positive-pressure ventilation with HEPA filtration.
• STRICT PROHIBITION OF RECTAL PROCEDURES: NO RECTAL TEMPERATURES, NO RECTAL SUPPOSITORIES, AND NO ENEMAS! Rectal mucosal tears allow dense gram-negative enteric flora to invade directly into the pelvic vasculature, triggering fatal polymicrobial and pseudomonal sepsis.
• Environmental Precautions: Strict avoidance of fresh cut flowers, potted plants, and standing water in the patient room, as plant soil and stagnant water harbor high concentrations of Pseudomonas aeruginosa and fungal spores (Aspergillus).
• Dietary Restrictions: Neutropenic or low-microbial diet—all foods must be thoroughly cooked; avoid raw or unpasteurized dairy, raw or undercooked meats, seafood, or eggs; thoroughly wash and peel all fresh fruits and vegetables.
• Daily Oral Hygiene: Soft foam toothed swabs or ultra-soft toothbrushes; alcohol-free chlorhexidine or saline rinses; strict avoidance of alcohol-based mouthwashes that exacerbate mucositis.